Chemical Name: N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid, disodium salt. Alternate Names: LY231514
Antifolate, antitumor agent
Molekulargewicht:
597.49
Reinheit:
98% by TLC and HPLC, NMR (Conforms)
Formulierung:
White solid
CAS Nummer:
[357166-29-1]
Formel:
C20H19N5O6 2Na 7H2O
Anwendungsbeschreibung:
Pemetrexed is a multi-targeted antifolate with antitumor activity. It potently inhibits folate-dependent enzymes involved in both purine and pyrimidine synthesis including thymidylate synthase (Ki = 109 nM), dihydrofolate reductase (Ki = 7 nM), glycinamide ribonucleotide formyltransferase (Ki = 9.3 µM), and aminoimidazole carboxamide ribonucleotide formyltransferase (Ki = 3.6 µM).1 A clinically useful anticancer agent.2 Indirectly activates the metabolic kinase AMPK and consequently influences the mTORC1 pathway in human carcinomas.3 Activation of AMPK is associated with pemetrexed resistance.4 Induces G0/G1-phase cell cycle arrest in esophageal squamous cell carcinoma cells.5
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten